Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by tillbillyon Nov 25, 2010 2:28pm

580 Views

Post# 17758027

RE: The boyz shaking the trees are getting tired..

Tree shakers or market makers? Could be some folks going short...which would be welcome. Never deny the shorty's...you need their money.
When your in a stock that's all bulls you have no downside protection.(Shorty's covering to take profits) Also you don't have the upside pop of shorty's peeing their pants and panic covering when the good news comes.Doubled up today and will hold to see a.25 re-test. If she breaks over .25 can't say when I'd sell. When she tests .25 (and she will) I'm out on a .235 reversal.
That's my plan.
GLTA

Bullboard Posts

Opawica seeks drill permits for Bazooka Gold Targets in Abitibi